Table 5 Methylation status of the TGFBI promoter in prostate cancer prostatectomy specimens with or without locoregional invasiveness
Locoregional invasiveness status of prostatectomy specimen | Number of methylated CpG sites | ||
|  | 0 | 5–10 | 16 |
Positive (n = 18) | 2 (11.1%) | 9 (50.0%) | 7 (38.9%)* |
Negative (n = 31) | 7 (22.6%) | 18 (58.1%) | 6 (19.4%)* |